Abstract
To the Editor: The paper in the September 3 issue by Santen et al.,1 comparing surgical adrenalectomy with“medical adrenalectomy”using aminoglutethimide in the treatment of advanced breast cancer makes a strong argument for the increased use of hormonal therapy, as discussed in the accompanying editorial.2 However, the comparison of the two therapies has serious methodologic errors. The authors state that they used a modification of the method of Zelen3 in designing a randomized trial wherein randomization preceded the obtaining of informed consent. Yet a key ingredient of Zelen's design is that patients who refuse the experimental treatment must.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 44-46 |
| Number of pages | 3 |
| Journal | New England Journal of Medicine |
| Volume | 306 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 7 1982 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- General Medicine
Fingerprint
Dive into the research topics of 'Aminoglutethimide vs. Surgical Adrenalectomy in Breast Cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver